Connect your AI

Evommune EVMN Accrued Compensation Shares Earned But Not Issued

Accrued Compensation Shares Earned But Not Issued at other companies

Matthews InternationalMATW

-$10.78M-256%

Mayville EngineeringMEC

$2.33M-11.5%

Korn FerryKFY

$64.42M+4.5%

Sharplink, Inc. SBET

$3.18M—

KrogerKR

$1.18B-2.2%

KforceKFRC

$37.75M+18.0%

Other financials

Income statement

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept meha:AccruedCompensationSharesEarnedButNotIssued.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's accrued compensation shares earned but not issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Evommune 's accrued compensation shares earned but not issued?: Evommune (EVMN) reported accrued compensation shares earned but not issued of $197.9K in Q1 2026.
What does accrued compensation shares earned but not issued mean?: Represents the value of equity-based compensation earned by employees or service providers that has been recognized as an expense but not yet settled through the issuance of shares. This metric reflects future dilution and the company's commitment to equity-based incentives for its workforce.